INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Narrative review / 2016

A review found limited evidence supporting chromium supplements for improving glycemic control in patients with type 2 diabetes.

This narrative review evaluated 20 randomized controlled trials to assess the efficacy of chromium supplements for glycemic control in type 2 diabetes patients. Clinically meaningful treatment goals were achieved with chromium in only 5 of 20 trials for fasting plasma glucose (FPG ≤7.2 mmol/dL), 3 of 14 for HbA1c (≤7%), and 1 of 14 for both; HbA1c declined by ≥0.5% in 5 of 14 studies. Based on the low strength of existing evidence, the authors concluded that chromium supplements show limited effectiveness for glycemic control in patients with existing type 2 diabetes.

Study type
Narrative review of 20 randomized controlled trials
Who was studied
Patients with type 2 diabetes mellitus across 20 randomized controlled trials
What was measured
Glycemic control, specifically decreases in fasting plasma glucose (FPG) and HbA1c

THE PAPER

Chromium supplements for glycemic control in type 2 diabetes: limited evidence of effectiveness.

Costello RB, Dwyer JT, Bailey RL. Nutr Rev, 2016.

PubMed 27261273 ↗DOI 10.1093/nutrit/nuw011 ↗

Diabetes & blood sugarNutrients & adequacy

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.